Infective endocarditis in an internal medicine ward;Estudio retrospectivo de la endocarditis infecciosa en diferentes grupos de riesgo

Revista Medica de Chile

Volumn 135, Issue 1, 2007, Pages 11-16

  Ameijeiras, Álvaro Hermida ^a,b   Rodríguez, Raimundo López ^a   Framil, Montserrat Rodríguez ^a   Lado, Francisco Lado ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Endocarditis, bacterial; Substance abuse, intravenous; Thromboembolism

Indexed keywords

ADULT; AGE; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; BACTERIAL ENDOCARDITIS; CHI SQUARE DISTRIBUTION; CROSS INFECTION; FEMALE; HUMAN; INFECTION; MALE; MICROBIOLOGY; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SPAIN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION; SUBSTANCE ABUSE; THROMBOEMBOLISM; VALVULAR HEART DISEASE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS; THROMBOEMBOLISM; VIRIDANS STREPTOCOCCI;

EID: 33947114010     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. MOREILLON P, QUE Y. Infective endocarditis. Lancet 2004; 363: 139-49.
2. DI SALVO G, ROSENBERG V, PERGOLA V, BELLIARD O, DERUMEAUX G, COHEN A ET AL. Endocarditis in the elderly: clinical, echocardiographic, and prognostic features. Eur Heart J 2003; 24: 1575-82.
3. WATKIN RW, LANG S, LAMBERT PA, LITTLER WA, ELLIOTT TSJ. The microbial diagnosis of infective endocarditis. J Infect 2003; 47: 1-11.
4. DURACK DT, LUKES AS, BRIGHT DK, AND THE DUKE ENDOCARDITIS SERVICE. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994; 96: 200-9.
5. LI JS, SEXTON DJ, NETTLES R, FOWLER VG, RYAN T, BASHORA T, COREY GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-8.
6. WERNER M, ANDERSSON R, OLAISON L, HOGEVIK H. A clinical study of culture-negative endocarditis. Medicine 2003; 82: 263-73.
7. AMERICAN COLLEGE OF CARDIOLOGY/A MERICAN HEART ASSOCIATION TASK FORCE ON PRACTICE GUIDELINES: Guidelines for the management of patients with valvular heart disease. Circulation 1998; 98: 1949-84.
8. BEN-AMI R, GILADI M, CARMELI Y, ORNI-WASSERLAUF R, SIEGMAN-IGRA Y. Hospital acquired infective endocarditis. Should the definition be broadered? Clin Infect Dis 2004; 38: 843-50.
9. BENN M, HAGELSKJAER LH, TVEDE M. Infective endocarditis, 1984 through 1993: a clinical and microbiological survey. J Int Med 1997; 242: 15-22.
10. NETZER RO, ZOLLINGER E, SEILER C, CERNY A. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria. Clin Infect Dis 1999; 28: 933-4.
11. CRUZ JM, MARTÍNEZ R, GARCÍA M, ZARZALEJOS JM, DE LA PEÑA F. Infective endocarditis in the elderly. An Med Interna 2003; 20: 569-74.
12. LAMAS CC, EYKYN SJ. Hospital acquired native valve endocarditis: analysis of 22 cases presenting over 11 years. Heart 1998; 79: 442-7.
13. FABER M, FRIMODT-MOLLER N, ESPERSEN F, SKINHOJ P, ROSDAHL V. Staphylococcus aureus endocarditis in Danish intravenous dug users: high proportion of left-sided endocarditis. Scand J Infect Dis 1995; 27: 483-7.
14. MANGONI DE, ADINOLFI LE, TRIPODI MF, ANDREANA A, GAMBARDELLA M, RAGONE E ET AL. Risk factors for major embolia events in hospitalized patients with infective endocarditis. Am Heart J 2003; 146: 311-6.
15. THE SEVENTH ACCP CONFERENCE ON ANTITHROMBOTIC AND THROMBOLYTIC THERAPY. Antithrombotic therapy in valvular heart disease-native and prosthetic. Chest 2004; 126: 457S-482S.
16. KUPFERWASER L, YEAMAN MR, SHAPIRO SM, NAST CL, SULLAM PM, FILLER SG ET AL. AAS reduces vegetation bacteria density, hematogenous bacterial dissemination and frequency of embolic events in experimental Staphilococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999; 99: 2791-7.